Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in Communities

IRVING, TX, and THOUSAND OAKS, CA, Dec. 4, 2020 —McKesson and Amgen (NASDAQ:AMGN), one of the world’s leading biotechnology companies, have signed a strategic agreement to help improve cancer care in community oncology settings. Today, 1 in 5 cancer patients receives an Amgen medicine, while McKesson...
Source: McKesson News - Category: Information Technology Source Type: news